256 (PB244): Phase 1 clinical trial of the anti-LLT1 antibody ZM008 as monotherapy and in combination with pembrolizumab in advanced solid tumor patients

Saved in:
Bibliographic Details
Published in:European journal of cancer (1990) 2024-10, Vol.211, p.114773, Article 114773
Main Authors: Ghosh, M., Ribas, I. Garcia, Fuloria, J., Rivera, I. Rodriguez, Vandross, A., Tiwari, A., Dubey, A.K., Bhattacharjee, S., Manjunath, Y., Kashipathi, S., Mandal, T.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0959-8049
DOI:10.1016/j.ejca.2024.114773